Peregrine Pharmaceuticals, Inc.

Peregrine Pharmaceuticals, Inc. (Peregrine) is a clinical-stage biopharmaceutical company that manufactures and develops monoclonal antibodies for the treatment of cancer and viral infections. The Company is advancing three separate clinical programs with its compounds bavituximab and Cotara that are clinical candidates under its anti-phosphatidylserine (Anti-PS) therapeutics and tumor necrosis therapy (TNT) platforms. In addition to its clinical programs, Peregrine is performing pre-clinical research on bavituximab and an equivalent human antibody as a potential treatment for viral hemorrhagic ...


There are no scholarships at this time


There are no events at this time

Company Data on Peregrine Pharmaceuticals, Inc.
provided by Owler


Peregrine Pharmaceuticals, Inc. is hiring for these positions

Show me: All available jobs